Elicio Therapeutics, Inc. Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current
Elicio Therapeutics, Inc. (ELTX) had Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current of $0 as of 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Notes
us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent · last filed 2022-03-30
- 2021-12-31: Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current $0.00.
- 2021-09-30: Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current $0.00.
- 2021-06-30: Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current $0.00.
- 2021-03-31: Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current $0.00.
| Period end | Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-12 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 |
| 2021-02-09 | $18.64M 10-K · filed 2022-03-30 |
| 2020-12-31 | $26.00M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |